ArticleJournal of clinical medicine2026

Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine.

Chun-Fu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.